(0.25%) 5 144.25 points
(0.25%) 38 539 points
(0.36%) 17 910 points
(-0.76%) $83.21
(1.66%) $1.955
(-0.19%) $2 342.70
(1.09%) $27.55
(0.52%) $926.90
(-0.21%) $0.933
(-0.13%) $11.01
(-0.30%) $0.798
(0.75%) $92.56
Live Chart Being Loaded With Signals
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals...
Stats | |
---|---|
Šios dienos apimtis | 174 939 |
Vidutinė apimtis | 860 684 |
Rinkos kapitalizacija | 86.53B |
EPS | INR3.64 ( 2023-11-01 ) |
Last Dividend | INR2.50 ( 2023-08-10 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 41.79 |
ATR14 | INR1.311 (0.24%) |
Tūris Koreliacija
Jubilant Ingrevia Limited Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Jubilant Ingrevia Limited Koreliacija - Valiuta/Žaliavos
Jubilant Ingrevia Limited Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR47.40B |
Bruto pelnas: | INR21.59B (45.54 %) |
EPS: | INR19.34 |
FY | 2022 |
Pajamos: | INR47.40B |
Bruto pelnas: | INR21.59B (45.54 %) |
EPS: | INR19.34 |
FY | 2022 |
Pajamos: | INR49.14B |
Bruto pelnas: | INR19.56B (39.80 %) |
EPS: | INR29.98 |
FY | 2021 |
Pajamos: | INR6.79B |
Bruto pelnas: | INR3.09B (45.51 %) |
EPS: | INR3.41 |
Financial Reports:
No articles found.
Jubilant Ingrevia Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR2.50 (N/A) |
INR0 (N/A) |
INR2.50 (N/A) |
INR0 (N/A) |
INR2.50 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.350 | 2021-08-05 |
Last Dividend | INR2.50 | 2023-08-10 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | INR10.35 | -- |
Avg. Dividend % Per Year | 0.47% | -- |
Score | 1.95 | -- |
Div. Sustainability Score | 2.31 | |
Div.Growth Potential Score | 2.42 | |
Div. Directional Score | 2.36 | -- |
Year | Amount | Yield |
---|---|---|
2021 | INR0.350 | 0.13% |
2022 | INR5.00 | 0.85% |
2023 | INR5.00 | 0.95% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
APOLSINHOT.NS | Dividend Junior | 2023-09-22 | Annually | 10 | 0.11% | |
TDPOWERSYS.NS | Dividend Junior | 2023-08-02 | Annually | 13 | 0.31% | |
OLECTRA.NS | Dividend Junior | 2023-09-21 | Sporadic | 23 | 0.03% | |
INTENTECH.NS | Dividend Junior | 2023-09-21 | Annually | 6 | 0.44% | |
COROMANDEL.NS | Dividend Knight | 2023-07-13 | Annually | 19 | 1.02% | |
SHALBY.NS | Dividend Junior | 2023-08-08 | Annually | 6 | 0.51% | |
MANALIPETC.NS | Dividend Junior | 2023-09-15 | Annually | 18 | 1.50% | |
GPPL.NS | Dividend Knight | 2023-07-26 | Semi-Annually | 9 | 2.89% | |
AXISBANK.NS | Dividend Junior | 2023-07-06 | Sporadic | 26 | 0.06% | |
TRU.NS | Dividend Junior | 2023-09-18 | Annually | 3 | 0.01% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0494 | 1.500 | 9.01 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0768 | 1.500 | -0.258 | -0.387 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 7.33 | 1.000 | 8.40 | 8.40 | [3 - 30] |
operatingCashFlowPerShareTTM | 12.81 | 2.00 | 5.73 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 12.81 | 2.00 | 3.60 | 7.19 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.470 | 1.000 | 5.51 | 5.51 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0787 | 1.000 | -0.426 | -0.426 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.31 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 42.00 | 1.000 | 5.86 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0768 | 2.50 | -0.166 | -0.387 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 12.81 | 2.00 | 5.73 | 7.19 | [0 - 30] |
dividendYielPercentageTTM | 0.919 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 12.81 | 2.00 | 5.73 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -1.183 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0488 | 1.000 | -1.279 | 0 | [0.1 - 0.5] |
Total Score | 2.42 |
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.